February 26, 2020 / 6:22 PM / a month ago

Three-month estimate for coronavirus vaccine's human trials too aggressive - FDA

(Reuters) - A U.S. Food and Drug Administration official said on Wednesday that the three-month estimate for coronavirus vaccine to enter human trials may be too aggressive.

“We’re hoping in next quarter or 2 there will be a vaccine that will be ready to move” into human trials, Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said at a conference in New York.

Reporting by Ankur Banerjee in Bengaluru and Mike Erman in New York; Editing by Anil D'Silva

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below